Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | TACR2 | P21452 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | SHBG | P04278 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.63 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | TST | Q16762 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27627903 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL10587047 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL29162246 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL27994729 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL9850692 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL282601 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL29162255 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL7466292 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL14193847 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL177157 | 1.00 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240284795-A1 | LIGHT EMITTING ELEMENT AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-22 | — | — | US | disclosed |
| CN-118359648-A | Light-emitting element and condensed polycyclic compound for light-emitting element | 三星显示有限公司 | 2024-07-19 | — | — | CN | disclosed |
| US-11858952-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-11802135-B2 | Lysophosphatidic acid derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-20230146210-A1 | NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20210347790-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| CN-107930695-B | Metal palladium complex polymer catalyst and carbon-carbon coupling reaction method using same | 华东理工大学 | 2020-09-08 | — | — | CN | disclosed |
| US-20160109803-A1 | PATTERNING PROCESS AND CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-04-21 | — | — | US | disclosed |
| US-9312501-B2 | Semiconducting compounds and optoelectronic devices incorporating same | POLYERA CORPORATION (US) | 2016-04-12 | — | — | US | disclosed |
| CN-102557896-B | (Poly) fluorine substituted phenyl diacetylene (bi) phenyl derivative, and preparation method and application thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD | 2015-03-11 | — | — | CN | disclosed |
| CN-102574868-B | Substituted benzochalcogenoacene compound, thin film comprising the compound, and organic semiconductor device including the thin film | SUMITOMO CHEMICAL CO | 2015-01-14 | — | — | CN | disclosed |
| WO-2013090041-A1 | SOLUTE-ENHANCED PRODUCTION OF GAMMA-VALEROLACTONE (GVL) FROM AQUEOUS SOLUTIONS LEVULINIC ACID | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-06-20 | — | — | WO | disclosed |
| WO-2012115369-A2 | TRIPHENYLENE-BASED REACTIVE MESOGEN CONTAINING ACETYLENE | 한국화학연구원 (KR) | 2012-08-30 | — | — | WO | disclosed |
| CN-101558110-B | Thermally stable cationic photocurable compositions | CIBA HOLDING INC | 2012-06-13 | — | — | CN | disclosed |
| CN-102117013-A | Photoresist composition | SUMITOMO CHEMICAL CO | 2011-07-06 | — | — | CN | disclosed |
| CN-101684166-A | Resin and chemically amplified resist composition comprising the same | SUMITOMO CHEMICAL CO | 2010-03-31 | — | — | CN | disclosed |
| CN-101558110-A | Thermally stable cationic photocurable compositions | CIBA HOLDING INC (CH) | 2009-10-14 | — | — | CN | disclosed |
| CN-1102623-C | Curing process for cationically photocurable formulation | CIBA SC HOLDING AG (CH) | 2003-03-05 | — | — | CN | disclosed |
| CN-1225109-A | Curing process for cationically photocurable formulation | CIBA SC HOLDING AG (CH) | 1999-08-04 | — | — | CN | disclosed |
| EP-0409634-A2 | Liquid crystal compounds and optically active compounds | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802135-B2 | Lysophosphatidic acid derivative | LPAR4, LPAR2, LPAR1 | ESR1 2409/4885ADRA2A 400/4885ADORA3 480/4885 |
| US-20210347790-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | BLVRB, CDYL, CRY1 | ESR1 515/4885ADRA2A 3803/4885ADORA3 4544/4885 |
| US-11858952-B2 | Compound and color conversion film comprising same | BLVRB, CDYL, CRY1 | ESR1 515/4885ADRA2A 3803/4885ADORA3 4544/4885 |
| US-20230146210-A1 | NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE | LPAR4, LPAR2, LPAR1 | ESR1 2619/4885ADRA2A 393/4885ADORA3 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.